Amber Therapeutics Limited
02826839 · Active
Company details
- Type
- Private Limited Company
- Incorporated
- 1993-06-14
- Country of origin
- United Kingdom
Accounts & filings
- Accounts last filed
- 2024-12-31 · TOTAL EXEMPTION FULL
- Next accounts due
- 2026-09-30 in 104 days
- Confirmation statement
- last made up 2025-06-14 · next due 2026-06-28
Registered office
Unit 1 Tech Foundry 2Curie Avenue
Didcot
Ox11 0qq
Peer comparison
Compared against 263 UK companies in SIC 72110 (Research and experimental development on biotechnology) within the Dormant or pre-trading bracket (Under £1k net assets).
See where this company ranks
Included with the £1 AI analysis unlock — one payment unlocks both for this company. Yours forever.
Based on this company's latest filed accounts (to Dec 2024) · Full accounts — profit & loss and balance sheet.
Unlock for £1Compares this company to 263 UK peers in Dormant or pre-trading bracket, by net assets, turnover, profitability, and more.
Financial health
Derived from the filed accounts to Dec 2024. Figures only — not advice.
See this company's financial health
£1 unlocks the liquidity & profitability ratios, risk signals, the AI analysis and peer comparison for this company. One payment, yours forever.
Based on this company's latest filed accounts (to Dec 2024) · Full accounts — profit & loss and balance sheet.
Unlock for £1Ratios and signals derived from this company's filed Companies House figures only.
Accounts
Based on this company's latest filed accounts (to Dec 2024) · Full accounts — profit & loss and balance sheet.
| Year ending | Dec 2024 | Dec 2023 | Jun 2023 | Jan 2023 | Jul 2022 |
|---|---|---|---|---|---|
| Profit & loss | |||||
| Profit / loss |
£-4,564,824
↓1027.8%
|
£-404,769
↓377.6%
|
£-84,747
|
— |
— |
| Balance sheet | |||||
| Fixed assets |
£199,240
↑1042.2%
|
£17,443
↑37.4%
|
£12,699
|
— |
— |
| Current assets |
£13,996,733
↑6575.9%
|
£209,661
↓29.4%
|
£296,906
|
— |
— |
| Cash |
£13,268,194
↑22250.9%
|
£59,363
↑555.7%
|
£9,053
|
— |
— |
| Debtors | — |
— |
£176,446
|
— |
— |
| Net current assets |
£-3,123,239
↓1038.0%
|
£-274,453
|
£86,167
|
— |
— |
| Net assets |
£-3,793,006
↓1059.9%
|
£-327,010
|
£77,759
|
— |
— |
| Equity |
£-3,793,006
↓1059.9%
|
£-327,010
|
£77,759
→0.0%
|
£77,759
↓52.2%
|
£162,506
|
| Other | |||||
| Average employees |
24
↑700.0%
|
3
↓25.0%
|
4
|
— |
— |
Source: filed iXBRL accounts at Companies House. P&L items are only published by medium and large companies; small companies file abridged or micro-entity accounts where the P&L is not public.
Industry (SIC codes)
Officers (11)
- Crawley, Aidan Harold Winston · Director appointed 2023-07-25
- Denison, Tim · Director appointed 2023-07-25 resigned 2025-02-05
- Gillbe, Ivor Stephen · Director appointed 2018-06-12 resigned 2023-07-25
- Spensley, John Hunter · Director appointed 2005-02-01 resigned 2023-07-25
- Viatge, Helene · Director appointed 2018-06-12 resigned 2019-10-31
- Wragg, Mark Charles · Director appointed 2014-08-27 resigned 2018-03-28
- Keeling, David Gordon · Director appointed 1993-06-14 resigned 2014-08-27
- Francis, David Robert Peter · Director appointed 2000-01-01 resigned 2003-06-30
- Keeling, John Ashley · Secretary appointed 1993-06-14 resigned 2000-01-01
- Fleet, Robert Thomas James · Director appointed 1993-06-14 resigned 1994-06-14
- Swift Incorporations Limited · Corporate Nominee Secretary appointed 1993-06-14 resigned 1993-06-14
People with significant control (2)
-
Bioinduction Medical Ltd Ceased 2024-07-22Corporate Entity Psc · notified 2018-06-30Ownership of shares 50 to 75 percent
-
Amber Therapeutics Holdings Limited ActiveCorporate Entity Psc · notified 2024-07-22Ownership of shares 75 to 100 percent Voting rights 75 to 100 percent Right to appoint and remove directors
Recent filings (15)
- 2025-11-03 Memorandum and articles (paper) MA Incorporation
- 2025-11-03 Statement of companys objects (paper) CC04 Change-Of-Constitution
- 2025-11-03 Resolution (paper) RESOLUTIONS Resolution
- 2025-10-31 Capital statement capital company with date currency figure (paper) SH19 Capital
- 2025-10-31 Legacy (paper) SH20 Capital
- 2025-10-31 Legacy (paper) CAP-SS Insolvency
- 2025-10-31 Resolution (paper) RESOLUTIONS Resolution
- 2025-10-30 Capital allotment shares SH01 Capital
- 2025-09-05 Total-exemption-full accounts AA Accounts
- 2025-06-27 Confirmation statement (with updates) CS01 Confirmation statement
- 2025-06-27 Notification of a person with significant control PSC02 PSC
- 2025-06-27 Cessation of a person with significant control PSC07 PSC
- 2025-06-18 Director details changed CH01 Officers
- 2025-06-17 Change registered office address company with date old address new address AD01 Address
- 2025-02-24 Termination director company with name termination date TM01 Officers
Showing the 15 most recent filings. View full filing history at Companies House.
Source: Companies House register